← Eichor
Study identifier: NCT06919614 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

STI Testing to Enhance PrEP Use in Pregnancy

Condition: PrEP Adherence · Sexually Transmitted Infections (STIs) · Pregnancy  ·  Sponsor: Botswana Harvard AIDS Institute Partnership

PhasePhase 3
Planned participants600
Who can joinFemale, N/A to no upper limit
Healthy volunteersYes

About this study

The investigators are conducting a study in Botswana to see if offering STI testing along with expanded HIV prevention options (PrEP) helps more pregnant women start and continue using PrEP during and after pregnancy. Pregnant women (n=600) seeking antenatal care in Botswana will be enrolled and randomly assigned to receive the standard of care (standard STI assessment with no STI testing) versus STI testing for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis during pregnancy and postpartum. The investigators' hypothesis is that providing STI testing alongside PrEP offer will encourage more women to start and continue using PrEP.

This description comes directly from the study's public registry record.

Talk to the study team

Chelsea Morroni, MBChB, DFSRH, MPH, PhD  ·  ‭+267 316 6657‬  ·  chelseaamorroni@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

DHMT ClinicsGaborone, BotswanaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06919614